![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2021
Chi, Kim N.; Chowdhury, Simon; Bjartell, Anders; Byung Ha, Chung; Gomes, Andrea J. Pereira de Santana; Given, Robert; Juarez, Alvaro; Merseburger, Axel S.; Ozguroglu, Mustafa; Uemura, Hirotsugu; Ye, Dingwei; Brookman-May, Sabine; Mundle, Suneel D.; McCarthy, Sharon A.; Larsen, Julie S.; Sun, Weili; Bevans, Katherine B.; Zhang, Ke; Bandyopadhyay, Nibedita und Agarwal, Neeraj
(2021):
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.
In: Journal of Clinical Oncology, Bd. 39, Nr. 20: S. 2294-2304
2020
Montesinos, Pau; Roboz, Gail J.; Bulabois, Claude-Eric; Subklewe, Marion; Platzbecker, Uwe; Ofran, Yishai; Papayannidis, Cristina; Wierzbowska, Agnieszka; Shin, Ho Jin; Doronin, Vadim; Deneberg, Stefan; Yeh, Su-Peng; Ozcan, Mehmet Ali; Knapper, Steven; Cortes, Jorge; Pollyea, Daniel A.; Ossenkoppele, Gert; Giralt, Sergio; Doehner, Hartmut; Heuser, Michael; Xiu, Liang; Singh, Indrajeet; Huang, Fei; Larsen, Julie S. und Wei, Andrew H.
(2020):
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study.
In: Leukemia, Bd. 35, Nr. 1: S. 62-74